Evidence map›Paper›PMID 41403437›Full record

Trial reportFrontiers in pharmacology2025

The median effective dose of esketamine with different doses of oliceridine during hysteroscopic surgery.

Min Shi, Tong Wang, Weiwei Wang, Jiafeng Wang, Lulu Li, Lulong Bo, Xiaolin Wang

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Min Shi *Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Tong Wang *Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Weiwei Wang *Department of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jiafeng WangDepartment of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Lulu LiDepartment of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Lulong BoDepartment of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Xiaolin WangDepartment of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to investigate the impact of different doses of oliceridine on the ED Methods: The trial was conducted involving 90 patients scheduled for elective hysteroscopy. Participants were allocated into three groups: control (0 mg oliceridine), group O1 (1 mg oliceridine), and group O2 (2 mg oliceridine). Anesthesia was induced with propofol, followed by a continuous infusion of propofol and a preset dose of esketamine. The primary outcome was the ED Results: The ED Conclusion: For hysteroscopic procedures, the co-administration of oliceridine was associated with a lower ED Trial Registration: www.chictr.org.cn, (ChiCTR2500101056); registration date: April 18, 2025.

Indexed as

50% effective doseanestheticsesketaminehysteroscopic surgeryoliceridine

Identifiers

PMID41403437
PMCPMC12702736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.